Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Diabetologia
    May 2025
  1. CIANGURA C, Seco A, Saint-Martin C, Ancel PY, et al
    Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities.
    Diabetologia. 2025;68:981-992.
    >> Share

    April 2025
  2. EEG-OLOFSSON K, Nathanson D, Spelman T, Kyhlstedt M, et al
    Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring.
    Diabetologia. 2025 Apr 24. doi: 10.1007/s00125-025-06438.
    >> Share

  3. ZHOU J, Mychaleckyj JC, Onengut-Gumuscu S, Orchard TJ, et al
    DNA methylation and 28 year incidence of two neuropathy phenotypes in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort study.
    Diabetologia. 2025 Apr 23. doi: 10.1007/s00125-025-06427.
    >> Share

  4. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Apr 21. doi: 10.1007/s00125-025-06430.
    >> Share

  5. BOULTON AJM, Jenkins AJ, Makkar B, Mankovsky B, et al
    Diabetes and natural and man-made disasters: prevention, preparation, response and recovery.
    Diabetologia. 2025 Apr 15. doi: 10.1007/s00125-025-06406.
    >> Share

  6. ZAPARDIEL-GONZALO J, Ziegler AG, Bonifacio E
    The genetic architecture of type 1 diabetes over time: how well can we rely on past data to predict the future?
    Diabetologia. 2025 Apr 12. doi: 10.1007/s00125-025-06422.
    >> Share

  7. SCHAIN M, Johansson E, Laitinen I, Froden Lowenmark A, et al
    Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-epsilon4.
    Diabetologia. 2025 Apr 11. doi: 10.1007/s00125-025-06405.
    >> Share

  8. BANGSHAAB M, Svart MV, Rittig N, Pedersen MGB, et al
    Metabolic effects of 3-hydroxybutyrate infusion in individuals with type 1 diabetes compared with healthy control participants: a randomised crossover trial showing intact feedback suppression of lipolysis.
    Diabetologia. 2025 Apr 10. doi: 10.1007/s00125-025-06423.
    >> Share

  9. PRASAD RB, Hakaste L, Tuomi T
    Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06419.
    >> Share

  10. VELMURUGAN S, Pandey VK, Verma N, Kotiya D, et al
    Cardiac remodelling, recognition memory deficits and accelerated ageing in a rat model of gestational diabetes.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06421.
    >> Share

  11. RIDDELL MC, Heller S, Carstensen L, Rocha TMP, et al
    The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1-5.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06414.
    >> Share

    March 2025
  12. KAYA S, Khamees A, Geerling G, Strzalkowski P, et al
    Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes.
    Diabetologia. 2025 Mar 31. doi: 10.1007/s00125-025-06407.
    >> Share

  13. MONTGOMERY MK, Lin S, Yang CH, Prasad K, et al
    HEXA-FC protein therapy increases skeletal muscle glucose uptake and improves glycaemic control in mice with insulin resistance and in a mouse model of type 2 diabetes.
    Diabetologia. 2025 Mar 29. doi: 10.1007/s00125-025-06413.
    >> Share

  14. DELIYANTI D, Suphapimol V, Joglekar A, Jayasimhan A, et al
    Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3(+) Tregs and CD8(+) T cells.
    Diabetologia. 2025 Mar 25. doi: 10.1007/s00125-025-06412.
    >> Share

  15. MORIERI ML, Rigato M, Frison V, D'Ambrosio M, et al
    Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study.
    Diabetologia. 2025 Mar 22. doi: 10.1007/s00125-025-06402.
    >> Share

  16. BONIFACIO E, Coelho R, Ewald DA, Gemulla G, et al
    The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes.
    Diabetologia. 2025 Mar 19. doi: 10.1007/s00125-025-06408.
    >> Share

  17. LAIHO JE, Oikarinen S, Morfopoulou S, Oikarinen M, et al
    Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06359.
    >> Share

  18. RODRIGUEZ-CALVO T, Laiho JE, Oikarinen M, Akhbari P, et al
    Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06384.
    >> Share

  19. RICHARDSON SJ, Rodriguez-Calvo T, Laiho JE, Kaddis JS, et al
    Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06401.
    >> Share

  20. LEE H, Fernandes M, Lee J, Merino J, et al
    Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications.
    Diabetologia. 2025 Mar 15. doi: 10.1007/s00125-025-06403.
    >> Share

  21. YANG Q, Zhu PW, Wen YJ, Zhang R, et al
    MAP4K4 aggravates microvascular anomalies in diabetic retinopathy in a YTHDF2-dependent manner.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06398.
    >> Share

  22. PITT M, Olvera-Barrios A, Anderson J, Bolter L, et al
    A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06379.
    >> Share

  23. ZHANG N, Sun Q, Zhang J, Zhang R, et al
    Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06392.
    >> Share

  24. SORENSEN KV, Justesen JM, Angquist L, Bork-Jensen J, et al
    Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA(1c) levels but not with type 2 diabetes.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06381.
    >> Share

  25. ZURIAGA MA, Fuster JJ
    Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complications.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06393.
    >> Share

  26. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
    Correction: Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06404.
    >> Share

  27. TSOI AT, Sng J, Tummanapalli SS, Issar T, et al
    Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes.
    Diabetologia. 2025 Mar 7. doi: 10.1007/s00125-025-06399.
    >> Share

  28. YIN W, Zou S, Sha M, Sun L, et al
    Gain of pancreatic beta cell-specific SCD1 improves glucose homeostasis by maintaining functional beta cell mass under metabolic stress.
    Diabetologia. 2025;68:629-645.
    >> Share

  29. REDONDO MJ, Cuthbertson D, Steck AK, Herold KC, et al
    Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes.
    Diabetologia. 2025;68:588-601.
    >> Share

  30. MORALES DD, Ryu J, Wei C, Hadley JT, et al
    Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells.
    Diabetologia. 2025;68:615-628.
    >> Share

  31. WANG Q, Leask MP, Lee K, Jaiswal J, et al
    The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice.
    Diabetologia. 2025;68:537-548.
    >> Share

    February 2025
  32. MOULDER R, Hirvonen MK, Valikangas T, Suomi T, et al
    Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06394.
    >> Share

  33. KOFOD DH, Diederichsen SZ, Bomholt T, Andersen MO, et al
    Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06388.
    >> Share

  34. SIMS EK, Cuthbertson D, Ferrat LA, Bosi E, et al
    IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06382.
    >> Share

  35. DING S, Xu JL, Tong JY, Cheng YY, et al
    Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease.
    Diabetologia. 2025 Feb 27. doi: 10.1007/s00125-025-06385.
    >> Share

  36. VERSCHUEREN VAN REES N, Ashwin P, McMullan C, Krogvold L, et al
    Beyond the loss of beta cells: a quantitative analysis of islet architecture in adults with and without type 1 diabetes.
    Diabetologia. 2025 Feb 26. doi: 10.1007/s00125-025-06376.
    >> Share

  37. CARLSSON PO, Espes D, Sisay S, Davies LC, et al
    Correction: Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
    Diabetologia. 2025 Feb 25. doi: 10.1007/s00125-025-06371.
    >> Share

  38. XIAO Q, Feng Q, Rutter MK, Albalak G, et al
    Associations between the timing of 24 h physical activity and diabetes mellitus: results from a nationally representative sample of the US population.
    Diabetologia. 2025 Feb 21. doi: 10.1007/s00125-025-06368.
    >> Share

  39. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
    Islet autoantibodies in Thai individuals individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
    Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-025-06373.
    >> Share

  40. VENKATARAGHAVAN S, Pankow JS, Boerwinkle E, Fornage M, et al
    Epigenome-wide association study of incident type 2 diabetes in Black and White participants from the Atherosclerosis Risk in Communities Study.
    Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-024-06352.
    >> Share

  41. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    How should we define subtypes of gestational diabetes mellitus? Reply to Gobl C, Tura A [letter].
    Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06375.
    >> Share

  42. GOBL C, Tura A
    How should we define subtypes of gestational diabetes mellitus?
    Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06374.
    >> Share

  43. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
    Diabetologia. 2025 Feb 12. doi: 10.1007/s00125-024-06350.
    >> Share

  44. KORNUM DS, Krogh K, Keller J, Malagelada C, et al
    Diabetic gastroenteropathy: a pan-alimentary complication.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06365.
    >> Share

  45. CALHOUN P, Spanbauer C, Steck AK, Frohnert BI, et al
    Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06362.
    >> Share

  46. DE MEULEMEESTER J, Keymeulen B, De Block C, Van Huffel L, et al
    One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06366.
    >> Share

  47. KOWALL B, Rathmann W
    Partnership and marriage and risk of type 2 diabetes: a narrative review.
    Diabetologia. 2025 Feb 7. doi: 10.1007/s00125-025-06360.
    >> Share

  48. LIN YK, Ye W, Hepworth E, Agni A, et al
    Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort.
    Diabetologia. 2025;68:433-443.
    >> Share

  49. HANSEN AL, Christiansen CF, Brons C, Engelhard LM, et al
    Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort.
    Diabetologia. 2025 Feb 1. doi: 10.1007/s00125-024-06357.
    >> Share

    January 2025
  50. FAN KS, Manoli A, Baumann PM, Shojaee-Moradie F, et al
    Comparison of continuous glucose monitoring with self-monitoring of blood glucose in type 1 diabetes in the changing atmospheric pressures in aviation: a hypobaric flight simulation.
    Diabetologia. 2025 Jan 31. doi: 10.1007/s00125-025-06364.
    >> Share

  51. ZHUANG S, Sun N, Qu J, Chen Q, et al
    High glucose/ChREBP-induced Hif-1alpha transcriptional activation in CD4(+) T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response.
    Diabetologia. 2025 Jan 30. doi: 10.1007/s00125-024-06354.
    >> Share

  52. FLOYD JL, Prasad R, Dupont MD, Adu-Rutledge Y, et al
    Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes.
    Diabetologia. 2025 Jan 28. doi: 10.1007/s00125-024-06349.
    >> Share

  53. MUELLER J, Breeze P, Fusco F, Sharp SJ, et al
    Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagn
    Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06355.
    >> Share

  54. COLLINS J, Farnsworth NL
    Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers.
    Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06356.
    >> Share

  55. MENDOZA K, Barquera S, Tobias DK
    Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions.
    Diabetologia. 2025 Jan 18. doi: 10.1007/s00125-025-06358.
    >> Share

  56. LINGVAY I, Benamar M, Chen L, Fu A, et al
    Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
    Diabetologia. 2025 Jan 17. doi: 10.1007/s00125-024-06348.
    >> Share

  57. CHEN Z, Qian F, Liu B, Zong G, et al
    Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women.
    Diabetologia. 2025 Jan 14. doi: 10.1007/s00125-024-06353.
    >> Share

  58. PACHECO LS, Tobias DK, Haslam DE, Drouin-Chartier JP, et al
    Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults.
    Diabetologia. 2025 Jan 8. doi: 10.1007/s00125-024-06351.
    >> Share

  59. HIRVELA L, Haukka J, Keski-Rahkonen A, Sipila PN, et al
    Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort.
    Diabetologia. 2025 Jan 4. doi: 10.1007/s00125-024-06346.
    >> Share

  60. CHIMIENTI R, Torchio S, Siracusano G, Zamarian V, et al
    A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome.
    Diabetologia. 2025;68:128-151.
    >> Share

  61. FU Q, Dai H, Shen S, He Y, et al
    Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function.
    Diabetologia. 2025;68:116-127.
    >> Share

  62. AHN M, Dhawan S, McCown EM, Garcia PA, et al
    Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis.
    Diabetologia. 2025;68:152-165.
    >> Share

    December 2024
  63. NADEAU KJ, Arslanian SA, Bacha F, Caprio S, et al
    Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06327.
    >> Share

  64. COLE A, Weight N, Misra S, Grapsa J, et al
    Correction: Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06337.
    >> Share

  65. SHAPIRO MR, Tallon EM, Brown ME, Posgai AL, et al
    Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06339.
    >> Share

  66. WERNROTH ML, Kennedy B, Fall K, Nguyen D, et al
    Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06340.
    >> Share

  67. BITARAFAN V, Anjom-Shoae J, Rezaie P, Fitzgerald PCE, et al
    Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study.
    Diabetologia. 2024 Dec 18. doi: 10.1007/s00125-024-06344.
    >> Share

  68. KRISTENSEN FPB, Domazet SL, Nielsen JS, Stidsen JV, et al
    Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06342.
    >> Share

  69. PERKINS BA, Turner LV, Riddell MC
    Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06317.
    >> Share

  70. SMEIJER JD, de Vries ST, Kohan DE, Hou FF, et al
    Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06326.
    >> Share

  71. DE VRIES ST, Pena MJ, Tye SC, Peters SAE, et al
    Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325.
    >> Share

  72. MOSER O, Zaharieva DP, Adolfsson P, Battelino T, et al
    The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPA
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06308.
    >> Share

  73. BROWN ME, Thirawatananond P, Peters LD, Kern EJ, et al
    Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function.
    Diabetologia. 2024 Dec 5. doi: 10.1007/s00125-024-06329.
    >> Share

  74. MACKENBACH JD, Stuber JM, Beulens JWJ
    Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06330.
    >> Share

  75. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06334.
    >> Share

  76. VIRTANEN JK, Hantunen S, Kallio N, Lamberg-Allardt C, et al
    The effect of vitamin D(3) supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06336.
    >> Share

  77. CHEN Y, Torta F, Koh HWL, Benke PI, et al
    Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06324.
    >> Share

  78. ZEMSKI BERRY KA, Garfield A, Jambal P, Zarini S, et al
    Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle.
    Diabetologia. 2024;67:2819-2832.
    >> Share

  79. WAT LW, Svensson KJ
    Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases.
    Diabetologia. 2024;67:2626-2636.
    >> Share

    November 2024
  80. TRICO D, Sacchetta L, Rebelos E, Cimbalo N, et al
    Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications.
    Diabetologia. 2024 Nov 29. doi: 10.1007/s00125-024-06312.
    >> Share

  81. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
    Correction: Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Diabetologia. 2024 Nov 27. doi: 10.1007/s00125-024-06335.
    >> Share

  82. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    Correction: A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Nov 25. doi: 10.1007/s00125-024-06332.
    >> Share

  83. O CK, Fan B, Tsoi STF, Tam CHT, et al
    A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
    Diabetologia. 2024 Nov 23. doi: 10.1007/s00125-024-06320.
    >> Share

  84. GALDERISI A, Sims EK, Evans-Molina C, Petrelli A, et al
    Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06323.
    >> Share

  85. LAESSER CI, Piazza C, Schorno N, Nick F, et al
    Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06319.
    >> Share

  86. YU G, Tam CHT, Lim CKP, Shi M, et al
    Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06309.
    >> Share

  87. ROONEY MR, Wallace AS, Echouffo Tcheugui JB, Fang M, et al
    Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06315.
    >> Share

  88. PHILLIPS NE, Mareschal J, Biancolin AD, Sinturel F, et al
    The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06318.
    >> Share

  89. WANG E, Patorno E, Khosrow-Khavar F, Crystal S, et al
    Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019.
    Diabetologia. 2024 Nov 8. doi: 10.1007/s00125-024-06321.
    >> Share

  90. AMR RA, Al-Smadi AM, Akasheh RT
    Diabetes knowledge and behaviour: a cross-sectional study of Jordanian adults.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06304.
    >> Share

  91. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06314.
    >> Share


  92. Correction: 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes, Madrid, Spain, 9-13 September 2024. 'Average glucose and HbA(1c) display a nonlinear and variable relationship: implications for clinical practice'.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06294.
    >> Share

  93. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
    Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06316.
    >> Share

  94. GOTTMANN P, Speckmann T, Stadion M, Chawla P, et al
    Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06301.
    >> Share

  95. RAO C, Cater DT, Roy S, Xu J, et al
    Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8(+) T cell activity and biomarker during the evolution of type 1 diabetes.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06313.
    >> Share

  96. MA RCW, Tam CHT, Hou Y, Lau ESH, et al
    NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06299.
    >> Share

  97. GESUITA R, Eckert AJ, Besancon S, Crimmins NA, et al
    Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry.
    Diabetologia. 2024 Nov 6. doi: 10.1007/s00125-024-06283.
    >> Share

  98. MEIER DT, de Paula Souza J, Donath MY
    Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06306.
    >> Share

  99. GARDEN GL, Fan KS, Paterson M, Shojaee-Moradie F, et al
    Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06295.
    >> Share

  100. GLINTBORG D, Christensen LL, Andersen MS
    Transgender healthcare: metabolic outcomes and cardiovascular risk.
    Diabetologia. 2024;67:2393-2403.
    >> Share


  101. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
    Diabetologia. 2024;67:2375-2392.
    >> Share

    October 2024
  102. HOSTRUP PE, Schmidt T, Hellsten SB, Gerwig RH, et al
    Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06290.
    >> Share

  103. TSAI YH, OjiNjideka Hemphill N, Kurth T
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06300.
    >> Share

  104. VOETS PJGM
    A modified total body water deficit formula for use in diabetes care.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06311.
    >> Share

  105. HANNA SJ, Bonami RH, Corrie B, Westley M, et al
    The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06298.
    >> Share

  106. SANTOSO C, Wei Y, Ahlqvist E, Tuomi T, et al
    Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06303.
    >> Share

  107. EDSTORP J, Rossides M, Ahlqvist E, Alfredsson L, et al
    Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case-control study (ESTRID) and the Norwegian HUNT study.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06302.
    >> Share

  108. NATHANSON D, Eeg-Olofsson K, Spelman T, Bulow E, et al
    Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA(1c) and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies.
    Diabetologia. 2024 Oct 26. doi: 10.1007/s00125-024-06289.
    >> Share

  109. MALLONE R
    Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Oct 24. doi: 10.1007/s00125-024-06296.
    >> Share

  110. CHILUNGA FP, Mkoma GF
    GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap.
    Diabetologia. 2024 Oct 21. doi: 10.1007/s00125-024-06297.
    >> Share

  111. APAOLAZA PS, Chen YC, Grewal K, Lurz Y, et al
    Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.
    Diabetologia. 2024 Oct 15. doi: 10.1007/s00125-024-06275.
    >> Share

  112. CERIELLO A, Prattichizzo F, Berra C
    Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complications.
    Diabetologia. 2024 Oct 4. doi: 10.1007/s00125-024-06284.
    >> Share

  113. COLE A, Weight N, Mishra S, Grapsa J, et al
    Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Oct 3. doi: 10.1007/s00125-024-06281.
    >> Share

  114. ZHAO LP, Papadopoulos GK, Skyler JS, Pugliese A, et al
    Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.
    Diabetologia. 2024 Oct 1. doi: 10.1007/s00125-024-06274.
    >> Share

  115. OKURA T, Ito Y, Anno M, Endo S, et al
    Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.
    Diabetologia. 2024;67:2304-2315.
    >> Share

  116. YAMAGUCHI M, Nakao S, Arima M, Little K, et al
    Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation.
    Diabetologia. 2024;67:2329-2345.
    >> Share

  117. WU Y, Yang M, Wu SB, Luo PQ, et al
    Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.
    Diabetologia. 2024;67:2346-2366.
    >> Share

  118. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:2210-2224.
    >> Share

  119. GRENKO CM, Taylor HJ, Bonnycastle LL, Xue D, et al
    Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h.
    Diabetologia. 2024;67:2246-2259.
    >> Share

    September 2024
  120. LIU S, Zhu J, Zhong H, Wu C, et al
    Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06277.
    >> Share

  121. SHARMA S, Dong Q, Haid M, Adam J, et al
    Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06282.
    >> Share

  122. HOLMAN N, Yelland AC, Young B, Valabhji J, et al
    Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management.
    Diabetologia. 2024 Sep 27. doi: 10.1007/s00125-024-06262.
    >> Share

  123. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Sep 21. doi: 10.1007/s00125-024-06272.
    >> Share

  124. ELBARBARY NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, et al
    The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.
    Diabetologia. 2024 Sep 14. doi: 10.1007/s00125-024-06265.
    >> Share

  125. TSATSARIS G, Rajamand Ekberg N, Fall T, Catrina SB, et al
    Risk factors for Charcot foot development in individuals with diabetes mellitus.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06271.
    >> Share

  126. HEIKKILA TE, Kaiser EK, Lin J, Gill D, et al
    Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06267.
    >> Share

  127. LAVENS A, De Block C, Oriot P, Crenier L, et al
    Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06273.
    >> Share


  128. 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Madrid, Spain, 9 - 13 September 2024.
    Diabetologia. 2024 Sep 12. doi: 10.1007/s00125-024-06226.
    >> Share

  129. GALINDO RJ, Soliman D, Chernavvsky D, Rhee CM, et al
    Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Sep 10. doi: 10.1007/s00125-024-06278.
    >> Share

  130. LENZEN S
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes.
    Diabetologia. 2024 Sep 7. doi: 10.1007/s00125-024-06264.
    >> Share

  131. SORIA-CONTRERAS DC, Wang S, Liu J, Lawn RB, et al
    Lifetime history of gestational diabetes and cognitive function in parous women in midlife.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06270.
    >> Share

  132. WACHOWSKI NA, Pippin JA, Boehm K, Lu S, et al
    Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06261.
    >> Share

  133. EIZIRIK DL, Zimath PL, Yi X, Roca Rivada A, et al
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter].
    Diabetologia. 2024 Sep 5. doi: 10.1007/s00125-024-06269.
    >> Share

  134. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Correction to: Consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Sep 4. doi: 10.1007/s00125-024-06266.
    >> Share

  135. THOMSON RL, Brown JD, Oakey H, Palmer K, et al
    Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study.
    Diabetologia. 2024 Sep 2. doi: 10.1007/s00125-024-06259.
    >> Share

  136. ESSER N, Hogan MF, Templin AT, Akter R, et al
    The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.
    Diabetologia. 2024;67:1897-1911.
    >> Share

  137. LITHOVIUS V, Lahdenpohja S, Ibrahim H, Saarimaki-Vire J, et al
    Non-invasive quantification of stem cell-derived islet graft size and composition.
    Diabetologia. 2024;67:1912-1929.
    >> Share

  138. WREVEN E, Ruiz de Adana MS, Hardiville S, Gmyr V, et al
    Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
    Diabetologia. 2024;67:1877-1896.
    >> Share

  139. MAKINEN S, Sree S, Ala-Nisula T, Kultalahti H, et al
    Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Diabetologia. 2024;67:1943-1954.
    >> Share

    August 2024
  140. DUNNE F, Newman C, Alvarez-Iglesias A, O'Shea P, et al
    Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE).
    Diabetologia. 2024 Aug 31. doi: 10.1007/s00125-024-06252.
    >> Share

  141. MALLIK R, Kar P, Mulder H, Krook A, et al
    The future is here: an overview of technology in diabetes.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06235.
    >> Share

  142. SCIBILIA R, Breslin-Brooker N, Bright C, Dzikiti T, et al
    Global experiences and personal narratives on diabetes technology and access.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06230.
    >> Share

  143. LIN DS, Lee JK, Huang KC, Lin TT, et al
    Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 29. doi: 10.1007/s00125-024-06257.
    >> Share

  144. FADINI GP, Longato E, Morieri ML, Bonora E, et al
    Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
    Diabetologia. 2024 Aug 23. doi: 10.1007/s00125-024-06251.
    >> Share

  145. TANABE H, Sato M, Miyake A, Shimajiri Y, et al
    Machine learning-based reproducible prediction of type 2 diabetes subtypes.
    Diabetologia. 2024 Aug 21. doi: 10.1007/s00125-024-06248.
    >> Share

  146. KHUNTI K, Zaccardi F, Amod A, Aroda VR, et al
    Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.
    Diabetologia. 2024 Aug 19. doi: 10.1007/s00125-024-06254.
    >> Share

  147. LEHNER CT, Schauberger G, Klug SJ
    Reduced type 2 diabetes incidence reflecting end of post?World War II calorie restrictions in Germany. Reply to Nilsson PM, Vaag A [letter].
    Diabetologia. 2024 Aug 17. doi: 10.1007/s00125-024-06255.
    >> Share

  148. PERKINS BA, Turner LV, Riddell MC
    Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06229.
    >> Share

  149. NILSSON PM, Vaag A
    Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in Germany.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06195.
    >> Share

  150. ADEBEKUN J, Nadig A, Saarah P, Asgari S, et al
    Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts.
    Diabetologia. 2024 Aug 14. doi: 10.1007/s00125-024-06247.
    >> Share

  151. SMITH K, Taylor GS, Peeters W, Walker M, et al
    Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06249.
    >> Share

  152. MALTESE G, McAuley SA, Trawley S, Sinclair AJ, et al
    Ageing well with diabetes: the role of technology.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06240.
    >> Share

  153. ELEFTHERIADOU A, Spallone V, Tahrani AA, Alam U, et al
    Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management.
    Diabetologia. 2024 Aug 9. doi: 10.1007/s00125-024-06242.
    >> Share

  154. GALINDO RJ, Soliman D, Chernasvvky D, Rhee CM, et al
    Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 8. doi: 10.1007/s00125-024-06244.
    >> Share

  155. YOU L, Ferrat LA, Oram RA, Parikh HM, et al
    Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06246.
    >> Share

  156. HAUKKA JK, Antikainen AA, Valo E, Syreeni A, et al
    Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06241.
    >> Share

  157. HURTADO I, Robles C, Peiro S, Garcia-Sempere A, et al
    Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06243.
    >> Share

  158. RASHID R, Chaudhry D, Evison F, Sharif A, et al
    Mortality risk for kidney transplant candidates with diabetes: a population cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06245.
    >> Share


  159. Up Front.
    Diabetologia. 2024;67:1453-1454.
    >> Share

  160. VISA M, Berggren PO
    Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca(2+) dynamics in prediabetic beta cells.
    Diabetologia. 2024;67:1663-1682.
    >> Share

  161. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:1588-1601.
    >> Share

  162. WINTHER-SORENSEN M, Garcia SL, Bartholdy A, Ottenheijm ME, et al
    Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
    Diabetologia. 2024;67:1602-1615.
    >> Share

    July 2024
  163. MASALIN S, Klavus A, Rono K, Koistinen HA, et al
    Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight.
    Diabetologia. 2024 Jul 31. doi: 10.1007/s00125-024-06237.
    >> Share

  164. SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
    The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06233.
    >> Share

  165. EHRMANN D, Hermanns N, Schmitt A, Klinker L, et al
    Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06239.
    >> Share

  166. VERNSTROM L, Gullaksen S, Sorensen SS, Ringgaard S, et al
    Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06228.
    >> Share

  167. LUNDGAARD AT, Westergaard D, Roder T, Burgdorf KS, et al
    Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06231.
    >> Share

  168. MOLVEAU J, Myette-Cote E, Tagougui S, Taleb N, et al
    Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Jul 29. doi: 10.1007/s00125-024-06234.
    >> Share

  169. KONDO A, McGrady M, Nallapothula D, Ali H, et al
    Spatial proteomics of human diabetic kidney disease, from health to class III.
    Diabetologia. 2024 Jul 22. doi: 10.1007/s00125-024-06210.
    >> Share

  170. DONOVAN LE, Bell RC, Feig DS, Lemieux P, et al
    Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes.
    Diabetologia. 2024 Jul 19. doi: 10.1007/s00125-024-06227.
    >> Share

  171. DU S, Sullivan VK, Fang M, Appel LJ, et al
    Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort.
    Diabetologia. 2024 Jul 13. doi: 10.1007/s00125-024-06221.
    >> Share

  172. SCULLY KJ, Marks BE, Putman MS
    Advances in diabetes technology to improve the lives of people with cystic fibrosis.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06223.
    >> Share

  173. SCHOELWER MJ, DeBoer MD, Breton MD
    Use of diabetes technology in children.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06218.
    >> Share

  174. WANG W, Bain SC, Bian F, Chen R, et al
    Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06142.
    >> Share

  175. JI L, Agesen RM, Bain SC, Fu F, et al
    Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06133.
    >> Share

  176. LUNA-MARCO C, Devos D, Cacace J, Fernandez-Reyes M, et al
    Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte-endothelial interactions.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06219.
    >> Share

  177. BROZZI F, Jacovetti C, Cosentino C, Menoud V, et al
    tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06207.
    >> Share

  178. DE WIT DF, Fuhri Snethlage CM, Rampanelli E, Maasen K, et al
    Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06213.
    >> Share

  179. MCLEAN A, Maple-Brown L, Murphy HR
    Technology advances in diabetes pregnancy: right technology, right person, right time.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06216.
    >> Share

  180. DONNELLY LA, McCrimmon RJ, Pearson ER
    Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06217.
    >> Share

  181. THABIT H, Schofield J
    Technology in the management of diabetes in hospitalised adults.
    Diabetologia. 2024 Jul 2. doi: 10.1007/s00125-024-06206.
    >> Share


  182. Up Front.
    Diabetologia. 2024;67:1163-1164.
    >> Share

  183. GYLFE E, Tengholm A
    Bo Hellman, 19 June 1930-4 December 2023.
    Diabetologia. 2024;67:1165-1167.
    >> Share

  184. BRAKENRIDGE CJ, Koster A, de Galan BE, Carver A, et al
    Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study.
    Diabetologia. 2024;67:1356-1367.
    >> Share

  185. HTOO PT, Tesfaye H, Schneeweiss S, Wexler DJ, et al
    Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
    Diabetologia. 2024;67:1328-1342.
    >> Share

    June 2024
  186. LIARAKOS AL, Lim JZM, Leelarathna L, Wilmot EG, et al
    The use of technology in type 2 diabetes and prediabetes: a narrative review.
    Diabetologia. 2024 Jun 29. doi: 10.1007/s00125-024-06203.
    >> Share

  187. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Correction: Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 Jun 28. doi: 10.1007/s00125-024-06199.
    >> Share

  188. XIAO Q, Full KM, Rutter MK, Lipworth L, et al
    Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans.
    Diabetologia. 2024 Jun 27. doi: 10.1007/s00125-024-06202.
    >> Share

  189. KENNEDY B, Wernroth ML, Batra G, Hammar U, et al
    Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06200.
    >> Share

  190. FUHRI SNETHLAGE CM, Balvers M, Ferwerda B, Rampanelli E, et al
    Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06204.
    >> Share

  191. BYNDLOSS M, Devkota S, Duca F, Niess JH, et al
    The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06198.
    >> Share

  192. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06205.
    >> Share

  193. D'ALESSIO DA, Kahn SE, Mulder H
    The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06208.
    >> Share

  194. UMPIERREZ GE, Davis GM, ElSayed NA, Fadini GP, et al
    Hyperglycaemic crises in adults with diabetes: a consensus report.
    Diabetologia. 2024 Jun 22. doi: 10.1007/s00125-024-06183.
    >> Share

  195. MUTHUKUMAR A, Badawy L, Mangelis A, Vas P, et al
    HbA(1c) variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes.
    Diabetologia. 2024 Jun 20. doi: 10.1007/s00125-024-06197.
    >> Share

  196. GAO L, Ramirez FJ, Cabrera JTO, Varghese MV, et al
    eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
    Diabetologia. 2024 Jun 19. doi: 10.1007/s00125-024-06201.
    >> Share

  197. KOBAYASHI Y, Long J, Johannsen NM, Talamoa R, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes? Reply to Pontes?Silva A, Santos?de?Araujo AD, Teixeira BC et al [letter].
    Diabetologia. 2024 Jun 18. doi: 10.1007/s00125-024-06181.
    >> Share

  198. WU M, Yoon CY, Park J, Kim G, et al
    The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Diabetologia. 2024 Jun 15. doi: 10.1007/s00125-024-06191.
    >> Share

  199. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2024 Jun 12. doi: 10.1007/s00125-024-06188.
    >> Share

  200. GUDEMANN LM, Young KG, Thomas NJM, Hopkins R, et al
    Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
    Diabetologia. 2024 Jun 5. doi: 10.1007/s00125-024-06190.
    >> Share

  201. VATANEN T, de Beaufort C, Marcovecchio ML, Overbergh L, et al
    Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.
    Diabetologia. 2024 Jun 4. doi: 10.1007/s00125-024-06192.
    >> Share

    May 2024
  202. ZHANG J, Zhang R, Liu C, Ge X, et al
    Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06186.
    >> Share

  203. SINGH T, Weiss A, Vehik K, Krischer J, et al
    Caesarean section and risk of type 1 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06176.
    >> Share

  204. JEVON D, Cottle L, Hallahan N, Harwood R, et al
    Capillary contact points determine beta cell polarity, control secretion and are disrupted in the db/db mouse model of diabetes.
    Diabetologia. 2024 May 30. doi: 10.1007/s00125-024-06180.
    >> Share

  205. GROEGLER J, Callebaut A, James EA, Delong T, et al
    The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.
    Diabetologia. 2024 May 29. doi: 10.1007/s00125-024-06164.
    >> Share

  206. SALVATORI B, Wegener S, Kotzaeridi G, Herding A, et al
    Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
    Diabetologia. 2024 May 27. doi: 10.1007/s00125-024-06184.
    >> Share

  207. DE MEULEMEESTER J, Charleer S, Visser MM, De Block C, et al
    The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    Diabetologia. 2024 May 24. doi: 10.1007/s00125-024-06171.
    >> Share

  208. FAGHERAZZI G, Aguayo GA, Zhang L, Hanaire H, et al
    Heterogeneity of glycaemic phenotypes in type 1 diabetes.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06179.
    >> Share

  209. JUMPERTZ VON SCHWARTZENBERG R, Vazquez Arreola E, Sandforth A, Hanson RL, et al
    Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06178.
    >> Share

  210. HANSEN AL, Brons C, Engelhard LM, Andersen MK, et al
    Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06170.
    >> Share

  211. CARLTON J, Powell PA, Broadley M, de Galan BE, et al
    Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06182.
    >> Share

  212. PONTES-SILVA A, Santos-de-Araujo AD, Teixeira BC, Carteri RB, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes?
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06121.
    >> Share

  213. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06169.
    >> Share

  214. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06175.
    >> Share

  215. DEL PRATO S, Torbeyns B, Mathieu C
    2024: The year to take European action on diabetes to the next level.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06166.
    >> Share

  216. SHEU A, White CP, Center JR
    Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06172.
    >> Share

  217. IBRAHIM H, Balboa D, Saarimaki-Vire J, Montaser H, et al
    RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function.
    Diabetologia. 2024 May 14. doi: 10.1007/s00125-024-06163.
    >> Share

  218. BOUGHTON CK, Hovorka R
    The role of automated insulin delivery technology in diabetes.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06165.
    >> Share

  219. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sanchez?Hernandez and Wagner [letter].
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06174.
    >> Share

  220. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06167.
    >> Share

  221. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
    New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
    Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
    >> Share

  222. RAUSCHER FG, Elze T, Francke M, Martinez-Perez ME, et al
    Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
    Diabetologia. 2024;67:928-939.
    >> Share

  223. RUISSEN MM, Steyerberg EW, Huisman SD, de Graaf AA, et al
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschenes SS [letter].
    Diabetologia. 2024;67:956-957.
    >> Share

  224. POUWER F, Deschenes S
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention.
    Diabetologia. 2024;67:954-955.
    >> Share

  225. IDEVALL-HAGREN O, Incedal Nilsson C, Sanchez G
    Keeping pace: the primary cilium as the conducting baton of the islet.
    Diabetologia. 2024;67:773-782.
    >> Share

    April 2024
  226. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Apr 30. doi: 10.1007/s00125-024-06135.
    >> Share

  227. TREVISAN R, Conti M, Ciardullo S
    Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
    Diabetologia. 2024 Apr 29. doi: 10.1007/s00125-024-06158.
    >> Share

  228. CHEN J, Feng Q, Qiao Y, Pan S, et al
    ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes.
    Diabetologia. 2024 Apr 27. doi: 10.1007/s00125-024-06156.
    >> Share

  229. STERNER ISAKSSON S, Imberg H, Hirsch IB, Schwarcz E, et al
    Discordance between mean glucose and time in range in relation to HbA(1c) in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
    Diabetologia. 2024 Apr 26. doi: 10.1007/s00125-024-06151.
    >> Share

  230. TAYLOR GS, Smith K, Scragg J, McDonald TJ, et al
    The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.
    Diabetologia. 2024 Apr 25. doi: 10.1007/s00125-024-06153.
    >> Share

  231. DENICOLO S, Reinstadler V, Keller F, Thoni S, et al
    Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
    Diabetologia. 2024 Apr 22. doi: 10.1007/s00125-024-06149.
    >> Share

  232. KIM JY, Jin SM, Sim KH, Kim BY, et al
    Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 19. doi: 10.1007/s00125-024-06152.
    >> Share

  233. KIM JY, Jin SM, Kang ES, Kwak SH, et al
    Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155.
    >> Share

  234. LI X, Donnelly LA, Slieker RC, Beulens JWJ, et al
    Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06147.
    >> Share

  235. SACCO S, Foschi M, Ornello R, De Santis F, et al
    Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06146.
    >> Share

  236. KARAGIANNIS T, Malandris K, Avgerinos I, Stamati A, et al
    Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06144.
    >> Share

  237. METSALA J, Risnes K, Persson M, Veijola R, et al
    Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06139.
    >> Share

  238. VALABHJI J, Holman N, Collins N, Young RJ, et al
    Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06134.
    >> Share

  239. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132.
    >> Share

  240. SIERRA-SILVESTRE E, Andrade RJ, Colorado LH, Edwards K, et al
    Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2024 Apr 5. doi: 10.1007/s00125-024-06138.
    >> Share

  241. LIU B, Xie D, Huang X, Jin S, et al
    Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1alpha.
    Diabetologia. 2024;67:724-737.
    >> Share

  242. XIE C, Iroga P, Bound MJ, Grivell J, et al
    Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
    Diabetologia. 2024 Apr 1. doi: 10.1007/s00125-024-06131.
    >> Share

    March 2024
  243. KORNUM DS, Bertoli D, Kufaishi H, Wegeberg AM, et al
    Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06129.
    >> Share

  244. VAN DEN BURG EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, et al
    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06137.
    >> Share

  245. MARCOVECCHIO ML, Hendriks AEJ, Delfin C, Battelino T, et al
    The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
    Diabetologia. 2024 Mar 22. doi: 10.1007/s00125-024-06124.
    >> Share

  246. TURNER LV, Marak MC, Gal RL, Calhoun P, et al
    Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06127.
    >> Share

  247. LUND-BLIX NA, Bjerregaard AA, Tapia G, Stordal K, et al
    No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06125.
    >> Share

  248. GUSTAFSON D, DiStefano PV, Wang XF, Wu R, et al
    Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.
    Diabetologia. 2024 Mar 15. doi: 10.1007/s00125-024-06120.
    >> Share

  249. MONTEYNE AJ, Falkenhain K, Whelehan G, Neudorf H, et al
    A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Mar 14. doi: 10.1007/s00125-024-06122.
    >> Share

  250. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
    Diabetologia. 2024 Mar 1. doi: 10.1007/s00125-024-06116.
    >> Share

    February 2024
  251. SU M, Hou Y, Cai S, Li W, et al
    Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06109.
    >> Share

  252. JIN Q, Lau ESH, Luk AO, Tam CHT, et al
    Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06108.
    >> Share

  253. REUTRAKUL S, Park JC, McAnany JJ, Chau FY, et al
    Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06118.
    >> Share

  254. TER BRAAKE JG, Fleetwood KJ, Vos RC, Blackbourn L, et al
    Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06111.
    >> Share

  255. COOMANS DE BRACHENE A, Alvelos MI, Szymczak F, Zimath PL, et al
    Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06106.
    >> Share

  256. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06113.
    >> Share

  257. SANCHEZ-HERNANDEZ RM, Wagner AM
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06115.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016